After hours: September 26 at 7:19 PM EDT ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

DNA methylation is one of the mechanisms hypothesised in the DOHaD model.20 Comprehensive epigenetic analysis will be performed to investigate DNA methylation in the umbilical cord,21 using a ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

The call was made by the founder of Chair Centre Group, Ibukun Awosika, at the ISCAN’s 48th Annual Conference, held on Thursday in Lagos. She stated that the conference’s theme: “Reassessing ...

Though Illumina said goodbye to Grail this past summer—after butting heads for years with antitrust regulators and activist investors, while enduring heavy fines and orders to split—the ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... New Therapy That Targets and ...

A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ:ILMN) 2021 acquisition of cancer test developer Grail (NASDAQ:GRAL), eliminating the ...

As part of this, Illumina aims to hire 100 technology professionals in India, including software engineers, IT hardware and network engineers, and system analysts in 2024 and 200 more by the end ...

As part of this, Illumina aims to hire over a hundred technology professionals in India, including software engineers, IT hardware and network engineers, and system analysts in 2024 and by the end ...